BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 35457030)

  • 21. Fusion of ALK to the melanophilin gene MLPH in pediatric Spitz nevi.
    Chung CT; Marrano P; Swanson D; Dickson BC; Thorner PS
    Hum Pathol; 2019 May; 87():57-64. PubMed ID: 30857967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and pathologic findings of Spitz nevi and atypical Spitz tumors with ALK fusions.
    Busam KJ; Kutzner H; Cerroni L; Wiesner T
    Am J Surg Pathol; 2014 Jul; 38(7):925-33. PubMed ID: 24698967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical, histopathologic, and genomic features of Spitz tumors with ALK fusions.
    Yeh I; de la Fouchardiere A; Pissaloux D; Mully TW; Garrido MC; Vemula SS; Busam KJ; LeBoit PE; McCalmont TH; Bastian BC
    Am J Surg Pathol; 2015 May; 39(5):581-91. PubMed ID: 25602801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-reactivity of NRASQ61R antibody in a subset of Spitz nevi with 11p gain: a potential confounding factor in the era of pathway-based diagnostic approach.
    Parra O; Lefferts JA; Tafe LJ; Gru AA; Linos K
    Hum Pathol; 2021 Jun; 112():35-47. PubMed ID: 33636207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features.
    Bastian BC; LeBoit PE; Pinkel D
    Am J Pathol; 2000 Sep; 157(3):967-72. PubMed ID: 10980135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic and epigenetic alterations in the differential diagnosis of malignant melanoma and spitzoid lesion.
    Takata M; Lin J; Takayanagi S; Suzuki T; Ansai S; Kimura T; Cerroni L; Saida T
    Br J Dermatol; 2007 Jun; 156(6):1287-94. PubMed ID: 17535228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spitz Melanocytic Tumors: A Fascinating 75-Year Journey.
    Chatzopoulos K; Syrnioti A; Linos K
    Genes (Basel); 2024 Jan; 15(2):. PubMed ID: 38397186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attempting to Solve the Pigmented Epithelioid Melanocytoma (PEM) Conundrum: PRKAR1A Inactivation Can Occur in Different Genetic Backgrounds (Common, Blue, and Spitz Subgroups) With Variation in Their Clinicopathologic Characteristics.
    de la Fouchardiere A; Tirode F; Castillo C; Buisson A; Boivin F; Macagno N; Pissaloux D
    Am J Surg Pathol; 2022 Aug; 46(8):1106-1115. PubMed ID: 35319526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spitz Tumors and Melanoma in the Genomic Age: A Retrospective Look at Ackerman's Conundrum.
    Urso C
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MAP2K1-Mutated Melanocytic Neoplasms With a SPARK-Like Morphology.
    Donati M; Nosek D; Waldenbäck P; Martinek P; Jonsson BA; Galgonkova P; Hawawrehova M; Berouskova P; Kastnerova L; Persichetti P; Crescenzi A; Michal M; Kazakov DV
    Am J Dermatopathol; 2021 Jun; 43(6):412-417. PubMed ID: 33264134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic comparison of malignant melanoma and atypical Spitz tumor in the pediatric population.
    Church AJ; Moustafa D; Pinches RS; Hawryluk EB; Schmidt BAR
    Pediatr Dermatol; 2022 May; 39(3):409-419. PubMed ID: 35194848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlating array comparative genomic hybridization findings with histology and outcome in spitzoid melanocytic neoplasms.
    Ali L; Helm T; Cheney R; Conroy J; Sait S; Guitart J; Gerami P
    Int J Clin Exp Pathol; 2010 Jun; 3(6):593-9. PubMed ID: 20661407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spitz Nevus and Other Spitzoid Tumors in Children. Part 2: Cytogenetic and Molecular Features. Prognosis and Treatment.
    Sainz-Gaspar L; Sánchez-Bernal J; Noguera-Morel L; Hernández-Martín A; Colmenero I; Torrelo A
    Actas Dermosifiliogr (Engl Ed); 2020 Jan; 111(1):20-25. PubMed ID: 31739993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NTRK3 kinase fusions in Spitz tumours.
    Yeh I; Tee MK; Botton T; Shain AH; Sparatta AJ; Gagnon A; Vemula SS; Garrido MC; Nakamaru K; Isoyama T; McCalmont TH; LeBoit PE; Bastian BC
    J Pathol; 2016 Nov; 240(3):282-290. PubMed ID: 27477320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of BRAF gene mutations differentiates spitz nevi from malignant melanoma.
    Mihic-Probst D; Perren A; Schmid S; Saremaslani P; Komminoth P; Heitz PU
    Anticancer Res; 2004; 24(4):2415-8. PubMed ID: 15330192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling Spitz melanoma in zebrafish using sequential mutagenesis.
    Mito JK; Weber MC; Corbin A; Murphy GF; Zon LI
    Dis Model Mech; 2022 Aug; 15(8):. PubMed ID: 36017742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical Spitz Tumors: A Diagnostic Challenge.
    Harms KL; Lowe L; Fullen DR; Harms PW
    Arch Pathol Lab Med; 2015 Oct; 139(10):1263-70. PubMed ID: 26414472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical, Morphologic, and Molecular Features of Benign and Intermediate-grade Melanocytic Tumors With Activating Mutations in MAP2K1.
    Fumero-Velázquez M; Hagstrom M; Dhillon S; Geraminejad T; Olivares S; Donati M; Nosek D; Waldenbäck P; Kazakov D; Sheffield BS; Tron VA; Gerami P
    Am J Surg Pathol; 2023 Dec; 47(12):1438-1448. PubMed ID: 37773074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinase fusions are frequent in Spitz tumours and spitzoid melanomas.
    Wiesner T; He J; Yelensky R; Esteve-Puig R; Botton T; Yeh I; Lipson D; Otto G; Brennan K; Murali R; Garrido M; Miller VA; Ross JS; Berger MF; Sparatta A; Palmedo G; Cerroni L; Busam KJ; Kutzner H; Cronin MT; Stephens PJ; Bastian BC
    Nat Commun; 2014; 5():3116. PubMed ID: 24445538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic Studies on a Case of Eruptive Disseminated Spitz Nevus and Review of Other 33 Cases.
    Fernandez-Flores A; Cassarino D
    Am J Dermatopathol; 2022 Dec; 44(12):989-1002. PubMed ID: 36395454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.